These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Value of MLH1 and MSH2 mutations in the appearance of Muir-Torre syndrome phenotype in HNPCC patients presenting sebaceous gland tumors or keratoacanthomas. Ponti G; Losi L; Pedroni M; Lucci-Cordisco E; Di Gregorio C; Pellacani G; Seidenari S J Invest Dermatol; 2006 Oct; 126(10):2302-7. PubMed ID: 16826164 [TBL] [Abstract][Full Text] [Related]
4. DNA mismatch repair defects and microsatellite instability status in periocular sebaceous carcinoma. Rajan Kd A; Burris C; Iliff N; Grant M; Eshleman JR; Eberhart CG Am J Ophthalmol; 2014 Mar; 157(3):640-7.e1-2. PubMed ID: 24321472 [TBL] [Abstract][Full Text] [Related]
5. Immunohistochemistry screening of sebaceous lesions for Muir-Torre syndrome in a 26-year period in a Mexican population. Archer-Dubon C; Alvarez-Zavala B; Reyes E; Orozco-Topete R Dermatol Online J; 2008 Dec; 14(12):1. PubMed ID: 19265614 [TBL] [Abstract][Full Text] [Related]
6. Muir-torre syndrome with intriguing squamous lesions: a case report and review of the literature. Nishizawa A; Nakanishi Y; Sasajima Y; Yamazaki N; Yamamoto A Am J Dermatopathol; 2006 Feb; 28(1):56-9. PubMed ID: 16456327 [TBL] [Abstract][Full Text] [Related]
7. Synchronous gastric and sebaceous cancers, a rare manifestation of MLH1-related Muir-Torre syndrome. Svec J; Schwarzová L; Janošíková B; Stekrová J; Mandys V; Kment M; Vodička P Int J Clin Exp Pathol; 2014; 7(8):5196-202. PubMed ID: 25197397 [TBL] [Abstract][Full Text] [Related]
8. Microsatellite instability and expression of hMLH-1 and hMSH-2 in sebaceous gland carcinomas as markers for Muir-Torre syndrome. Entius MM; Keller JJ; Drillenburg P; Kuypers KC; Giardiello FM; Offerhaus GJ Clin Cancer Res; 2000 May; 6(5):1784-9. PubMed ID: 10815898 [TBL] [Abstract][Full Text] [Related]
9. Mismatch repair proteins expression and microsatellite instability in skin lesions with sebaceous differentiation: a study in different clinical subgroups with and without extracutaneous cancer. Cesinaro AM; Ubiali A; Sighinolfi P; Trentini GP; Gentili F; Facchetti F Am J Dermatopathol; 2007 Aug; 29(4):351-8. PubMed ID: 17667167 [TBL] [Abstract][Full Text] [Related]
10. MSH-6: extending the reliability of immunohistochemistry as a screening tool in Muir-Torre syndrome. Chhibber V; Dresser K; Mahalingam M Mod Pathol; 2008 Feb; 21(2):159-64. PubMed ID: 18065960 [TBL] [Abstract][Full Text] [Related]
12. Fordyce granules and hyperplastic mucosal sebaceous glands as distinctive stigmata in Muir-Torre syndrome patients: characterization with reflectance confocal microscopy. Ponti G; Meschieri A; Pollio A; Ruini C; Manfredini M; Longo C; Mandel VD; Ciardo S; Tomasi A; Giannetti L; Pellacani G J Oral Pathol Med; 2015 Aug; 44(7):552-7. PubMed ID: 25213213 [TBL] [Abstract][Full Text] [Related]
13. [The tip of the iceberg: multiple cutaneous sebaceous tumor in colon cancer. Muir-Torre syndrome--case report]. Herr G; Szenes M; Hohl G; Vinkler ME; Tüske G; Horváth J; Nagy G; Tihanyi M; Széll M; Nagy N; Gasztonyi B Orv Hetil; 2015 Jun; 156(24):979-84. PubMed ID: 26051134 [TBL] [Abstract][Full Text] [Related]
14. More than just skin deep!: a report on a family with Muir-Torre syndrome. Jairam N; Shivaram HV; Murthy RA; Yadav N; Sathish N; Kumar V A; Payal K; Pandey V Int J Colorectal Dis; 2007 Aug; 22(8):987-9. PubMed ID: 16575605 [No Abstract] [Full Text] [Related]
15. Muir-Torre Syndrome / Turcot Syndrome overlap? A patient with sebaceous carcinoma, colon cancer, and a malignant astrocytoma. Kleinerman R; Marino J; Loucas E Dermatol Online J; 2012 May; 18(5):3. PubMed ID: 22630573 [TBL] [Abstract][Full Text] [Related]
16. Parotid Sebaceous Carcinoma in Patient with Muir Torre Syndrome, Caused by MSH2 Mutation. Neelakantan IV; Di Palma S; Smith CE; McCoombe A Head Neck Pathol; 2016 Sep; 10(3):354-61. PubMed ID: 26577210 [TBL] [Abstract][Full Text] [Related]
17. A genotype-phenotype correlation in HNPCC: strong predominance of msh2 mutations in 41 patients with Muir-Torre syndrome. Mangold E; Pagenstecher C; Leister M; Mathiak M; Rütten A; Friedl W; Propping P; Ruzicka T; Kruse R J Med Genet; 2004 Jul; 41(7):567-72. PubMed ID: 15235030 [No Abstract] [Full Text] [Related]
18. An illustrative case of Muir-Torre syndrome: contribution of immunohistochemical analysis in identifying indicator sebaceous lesions. Marazza G; Masouyé I; Taylor S; Prins C; Gaudin T; Saurat JH; French LE Arch Dermatol; 2006 Aug; 142(8):1039-42. PubMed ID: 16924054 [TBL] [Abstract][Full Text] [Related]
19. A Muir-Torre syndrome family. Serleth HJ; Kisken WA Am Surg; 1998 Apr; 64(4):365-9. PubMed ID: 9544152 [TBL] [Abstract][Full Text] [Related]
20. [Muir-Torre syndrome and familial colorectal cancer: 2 families with molecular genetic analysis]. Doré MX; Dieumegard B; Grandjouan S; Avril MF; Martinet C; Ducreux M; Lasser P; Bressac-de Paillerets B Ann Dermatol Venereol; 1999; 126(8-9):582-6. PubMed ID: 10530344 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]